TP53 and glioblastoma: We also demonstrated, using cell lines derived from glioblastoma, that CEP-1347 inhibited MDM4 in glioblastoma cells and that the down-regulation of MDM4 was sufficient to activate the p53 pathway, suggesting that CEP-1347 activated the p53-dependent growth inhibitory signal through the suppression of MDM4 [20].